Related Experiment Videos
Medical abortion in the first trimester.
1Centre for Reproductive Biology, University of Edinburgh, 37 Chalmers Street, UK.
Summary
Medical abortion using mifepristone and prostaglandins is a safe and effective method for terminating pregnancy. This treatment option is comparable to surgical procedures and is chosen by a majority of eligible women in countries where it is readily available.
Area of Science:
- Reproductive Health
- Pharmacology
- Obstetrics and Gynecology
Background:
- Medical abortion utilizes medication to safely terminate pregnancies.
- Mifepristone, a progesterone antagonist, and prostaglandins are key agents in medical abortion.
- This method has been licensed and widely adopted in Europe and the USA for early pregnancy termination.
Purpose of the Study:
- To review the safety and efficacy of medical abortion methods.
- To assess the impact of drug dosage, type, and administration route on outcomes.
- To evaluate the service requirements for successful medical abortion implementation.
Main Methods:
- Review of published data on medical abortion regimens.
- Analysis of mifepristone and prostaglandin combinations (e.g., 600 mg mifepristone followed by gemeprost or misoprostol).
- Comparison of medical abortion with surgical methods like vacuum aspiration.
Main Results:
- Medical abortion safety and efficacy are comparable to vacuum aspiration.
- Complete abortion rates depend on prostaglandin type/dose, route, gestation, and parity.
- Reducing mifepristone dose to 200 mg shows no loss of efficacy.
- Vaginal misoprostol is more effective and has fewer side-effects than oral administration.
Conclusions:
- Medical abortion is a safe and effective option for pregnancy termination.
- Optimized service delivery, including prompt referral and follow-up, is crucial for success.
- Increasing clinical experience reduces the need for surgical intervention.
- Medical abortion is the preferred method for 60-70% of eligible women in countries with established services.